Not finding it? Sign in to also search OpenAlex live.
-
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
Astrid E. Slagter, Irene A. Caspers, Nicole C.T. van Grieken, Iris Walraven, Pehr Lind, Elma Meershoek‐Klein Kranenbarg, +9 more
1citations -
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Joerg Heil, Henry M. Kuerer, André Pfob, Gaiane Margishvili Rauch, Hans‐Peter Sinn, Michael Golatta, +1 more
236citations -
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial
Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Camiel Rosman, Bo Jan Noordman, +36 more
127citations -
A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma2021 European Journal of Surgical Oncology article Medicine Sarcoma Diagnosis and Treatment Open access
Jules Lansu, Pètra M. Braam, Erik D. van Werkhoven, Astrid N. Scholten, Yvonne M. Schrage, Winan J. van Houdt, +2 more
20citations -
MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study
Fleur M. Louis, Anna van der Voort, Mette S. van Ramshorst, Antonios Daletzakis, Ingrid A.M. Mandjes, Inge Kemper, +49 more
8citations -
24P Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
B.V. Sinn, M. Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, Katharina Sychra, +12 more
0citations -
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials2021 The Lancet Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Carsten Denkert, Fenja Seither, Andreas Schneeweiß, Theresa Link, Jens‐Uwe Blohmer, Marianne Just, +28 more
584citations -
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access cited by 1 patent
Alba Llop‐Guevara, Sibylle Loibl, Guillermo Javierre Villacampa, Valentina A. Vladimirova, Andreas Schneeweiß, Thomas Karn, +14 more
107citations -
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial
Ulrike Anneliese Nitz, Oleg Gluz, Monika Graeser, Matthias Christgen, Sherko Küemmel, Eva‐Maria Grischke, +43 more
93citations -
LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial2023 Annals of Oncology conference-abstract Medicine Esophageal Cancer Research and Treatment Open access
Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Camiel Rosman, Bo Jan Noordman, +14 more
52citations -
Neo-adjuvant immunotherapy emerges as best medical practice, and will be the new standard of care for macroscopic stage III melanoma2023 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Alexander C. J. van Akkooi, Christian U. Blank, Alexander M.M. Eggermont
35citations -
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma2021 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Judith M. Versluis, Irene L. M. Reijers, Elisa A. Rozeman, Alexander Maxwell Menzies, Alexander C. J. van Akkooi, Michel W.J.M. Wouters, +7 more
29citations -
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial2025 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Rosa Di Micco, Steffi Hartmann, Maggie Banys‐Paluchowski, Jana de Boniface, Nina Caroline Ditsch, Elmar Stickeler, +23 more
18citations -
Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?2024 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
M. Loo, Layla Andour, Anne E. van Heesewijk, Hendrika M. Oosterkamp, Gerrit‐Jan Liefers, Marieke Evelien Straver
8citations -
1085P Health-related quality of life in stage III melanoma patients treated with neoadjuvant ipilimumab and nivolumab followed by index lymph node excision only versus therapeutic lymph node dissection: 24-week results of the PRADO trial
N.M.J. Van Den Heuvel, Irene L. M. Reijers, Judith M. Versluis, Elisa A. Rozeman, Katarzyna Jóźwiak, K.H. Blommers, +14 more
3citations -
Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial.
Paolo Giovanni Nuciforo, John Townend, Cristina Saura, E. de Azumbaja, Florentine Hilbers, Anna Manukyants, +13 more
3citations -
1095P Associations between baseline biomarkers and 3-year survival in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma
Irene L. M. Reijers, Petros Dimitriadis, Alexander Maxwell Menzies, Ellen Kapiteijn, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk, +13 more
2citations